MarketScreener Strategies Genome & Company
Stocks
A314130
KR7314130006
Biotechnology & Medical Research
|
End-of-day quote
Korea S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 3,175.00 KRW | -2.31% |
|
-7.57% | -53.85% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- A314130 Stock
- News Genome & Company
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
